Zoonotic Disease Clinical Trial
— MICROTONEOfficial title:
Viral and Microbial Circulation Between Humans, Domesticated and Wild Animals Along an Ecotone, Democratic Republic of Congo
Verified date | August 2023 |
Source | Institut Pasteur |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will evaluate the overlap between the intestinal microbiome and virome of wild and domesticated animals and human beings living in close proximity in three sites along an ecotone (ecological gradient) in the Democratic Republic of Congo.
Status | Completed |
Enrollment | 60 |
Est. completion date | September 21, 2021 |
Est. primary completion date | September 21, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age 18 years or older - Accept participation in study - Residing in one of three villages selected - In good health and able to conduct habitual daily activities - Accept self-collection of 2g of stool - Accept blood collection (2-2.5 ml) by a medical professional - Accept to self-collect daily activities and contacts with selected wild and domesticated animals for five months - Accept to participate in an anthropological-historical interview on changing practices and contacts with wild and domesticated animals Exclusion Criteria: - Vulnerable adults will not be included - Women who are pregnant or nursing at the time of recruitment and inclusion will not be included. - Adults declaring themselves ill and unable to conduct their habitual daily activities will not be included. - Adults with a chronic illness will not be included - Adults who have a family member already included in the study will not be included. - Adults refusing either recording of interviews or note-taking during interviews will not be included. |
Country | Name | City | State |
---|---|---|---|
Congo, The Democratic Republic of the | INRB | Kinshasa |
Lead Sponsor | Collaborator |
---|---|
Institut Pasteur | Centre National de la Recherche Scientifique, France, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, University Paris 7 - Denis Diderot |
Congo, The Democratic Republic of the,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of gut bacterial genera shared by included people | The investigators will evaluate the gut bacteria shared by humans on a daily basis. | 2 years (March 13, 2019 to March 13, 2021) | |
Primary | Percentage of gut bacterial genera shared by selected wild animals | The investigators will evaluate the gut bacteria shared by wild animals on a daily basis. | 2 years (March 13, 2019 to March 13, 2021) | |
Primary | Percentage of gut bacterial genera shared by selected domesticated animals | The investigators will evaluate the gut bacteria shared by domesticated animals living in proximity on a daily basis. | 2 years (March 13, 2019 to March 13, 2021) | |
Primary | Percentage of overlap (of viral genera) between human subjects and great apes | The percentage of overlap (of viral genera) between human subjects and great apes will be measured. | 2 years (March 13, 2019 to March 13, 2021) | |
Secondary | Description of Contact type | The investigators will evaluate the type of physical contact between human beings, wild animals and domesticated animals from data collected in self-reported daily activity tool. This outcome will be measured through identified categories of physical contact. We will also estimate how contact types have changed over time through an analysis of the historical, anthropological interview data. | 2 years (March 13,2019 to March 13, 2021) | |
Secondary | Contact frequency investigation | The investigators will evaluate the frequency of physical contact between human subjects and wild animals and domesticated animals from data collected in the self-reported daily activity collection tool. Frequency will be measured by the number per category of physical contact. | 2 years (March 13, 2019 to March 13, 2021) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04717622 -
Investigation of Fever Suspected as a Zoonosis Using Advanced Diagnostic Technologies
|
||
Completed |
NCT04495569 -
A Bridging Study of the SYN023 on Healthy Adult Subjects
|
Phase 1/Phase 2 |